Company Filing History:
Years Active: 2022
Title: Shay Eizenberger: Innovator in Peptide Research
Introduction
Shay Eizenberger is a notable inventor based in Rehovot, Israel. He has made significant contributions to the field of peptide research, particularly in the context of treating diseases associated with mutant p53 proteins. His innovative work has the potential to impact therapeutic strategies for various disorders.
Latest Patents
Eizenberger holds a patent for "Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant P53." This patent describes an isolated peptide that comprises an amino acid sequence arranged in a specific configuration. This configuration allows the peptide to interact with the DNA Binding Domain (DBD) of p53, facilitating the reactivation of a mutant p53 protein. The patent emphasizes that the peptide is distinct from certain specified sequences, ensuring its unique application in medical treatments. He has 1 patent to his name.
Career Highlights
Shay Eizenberger is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in peptide applications. His work is characterized by a commitment to exploring innovative solutions for complex medical challenges.
Collaborations
Eizenberger collaborates with esteemed colleagues, including Varda Rotter and Moshe Oren. Their combined expertise enhances the research environment and fosters innovative approaches to peptide development.
Conclusion
Shay Eizenberger's contributions to peptide research exemplify the intersection of innovation and medical science. His work holds promise for advancing treatments for diseases linked to mutant p53 proteins.